Home Compliance First Circuit Rejects Whistleblower’s Fraud on the FDA FCA Theory ComplianceExpert OpinionNews First Circuit Rejects Whistleblower’s Fraud on the FDA FCA Theory January 4, 2017 8 Share FacebookLinkedinTwitter You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Law Late is Late Update: eSimplicity Upheld Development Special Alert – Chemonics to pay $3.1 Million to Resolve Allegations of Fraudulent Billing under Supply Chain Contract Compliance The False Claims Act How a Recent Decision Rejecting Qui Tam Lawsuits May Affect Enforcement
